Showing 581 - 600 results of 92,418 for search '(( a ((we decrease) OR (teer decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.87s Refine Results
  1. 581
  2. 582
  3. 583

    Table_1_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.docx by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  4. 584

    Table_2_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.docx by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  5. 585

    Table_3_Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment.doc by Ying-Hsien Huang (446595)

    Published 2019
    “…After PCR validation, our data only revealed decreased NR4A2 mRNA expression in the KD patients compared to those of the controls, which increased after they received IVIG treatment. …”
  6. 586

    A flow diagram of the study entry. by Sakiko Fukui (387048)

    Published 2025
    “…Criteria included: at least six months’ residency before death, ability to eat orally during the study period, and death within the facility. We created a time-series dataset for 69 participants, documenting their average weekly food intake (on a scale of 0-10). …”
  7. 587

    Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

    Published 2015
    “…</p><p>Methods</p><p>In an 8-week single-arm open-label pilot study of empagliflozin, we compared ambulatory glucose profiles produced from CGM data during 2-week intervals in a placebo run-in baseline period, end-of-treatment, and post-treatment. …”
  8. 588
  9. 589
  10. 590
  11. 591

    RNA Interference in <em>Schistosoma mansoni</em> Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening by Saša Štefanić (239531)

    Published 2010
    “…Transient RNAi has emerged as a straightforward and important technique to interrogate that information through decreased or loss of gene function and identify potential drug targets. …”
  12. 592

    Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review by Weixin Wu (714474)

    Published 2015
    “…</p><p>Methods</p><p>We conducted a retrospective review of 333 patients with metastatic prostate cancer treated with docetaxel at a comprehensive cancer center between October 7, 2004 and December 31, 2012. …”
  13. 593
  14. 594

    Interaction strength in plant-pollinator networks: Are we using the right measure? by Roberto Novella-Fernandez (8119745)

    Published 2019
    “…Interaction evenness also decreased strongly with the visit-based approach. We conclude that accounting for the number of flowers visited per encounter provides a more ecologically relevant measure of interaction strength. …”
  15. 595
  16. 596

    NTM cells treated with TGFβ1 show increased expression of COL1A1 and DNMT1 and decreased expression of RASAL1. by Fiona McDonnell (2636635)

    Published 2016
    “…</b> Upon investigation of mRNA expression of COL1A1, DNMT1 and RASAL1 by qPCR, we found that COL1A1 (P<0.05) and DNMT1 were increased and RASAL1 (P<0.05) was decreased in the cells treated with TGFβ1. …”
  17. 597
  18. 598
  19. 599

    Table_1_Can We Boost Treatment Adherence to an Online Transdiagnostic Intervention by Adding Self-Enhancement Strategies? Results From a Randomized Controlled Non-inferiority Trial... by Andreea Bogdana Isbăşoiu (11784218)

    Published 2021
    “…By this mean we intend to complement the symptom-focused assignments, which may be more suitable in a therapist assisted context, with ones designed for self-enhancement, which may be easier approached as self-initiated. …”
  20. 600